TAYLOR MORRISON HOME CORP (TMHC) Stock Fundamental Analysis

NYSE:TMHC • US87724P1066

68.86 USD
+3.39 (+5.18%)
At close: Feb 13, 2026
68.86 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TMHC. TMHC was compared to 60 industry peers in the Household Durables industry. TMHC has an excellent profitability rating, but there are some minor concerns on its financial health. TMHC is cheap, but on the other hand it scores bad on growth. This makes TMHC very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year TMHC was profitable.
  • In the past year TMHC had a positive cash flow from operations.
  • TMHC had positive earnings in 4 of the past 5 years.
  • Of the past 5 years TMHC 4 years had a positive operating cash flow.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

  • TMHC has a better Return On Assets (8.84%) than 78.33% of its industry peers.
  • TMHC's Return On Equity of 13.76% is fine compared to the rest of the industry. TMHC outperforms 71.67% of its industry peers.
  • TMHC has a Return On Invested Capital of 10.86%. This is in the better half of the industry: TMHC outperforms 73.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TMHC is above the industry average of 9.16%.
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROIC 10.86%
ROA(3y)10.27%
ROA(5y)8.31%
ROE(3y)17.42%
ROE(5y)15.22%
ROIC(3y)12.32%
ROIC(5y)10.17%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • TMHC's Profit Margin of 10.16% is amongst the best of the industry. TMHC outperforms 85.00% of its industry peers.
  • In the last couple of years the Profit Margin of TMHC has grown nicely.
  • The Operating Margin of TMHC (14.53%) is better than 88.33% of its industry peers.
  • In the last couple of years the Operating Margin of TMHC has grown nicely.
  • TMHC's Gross Margin of 23.91% is in line compared to the rest of the industry. TMHC outperforms 43.33% of its industry peers.
  • TMHC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
OM growth 3Y8.83%
OM growth 5Y15.82%
PM growth 3Y6.96%
PM growth 5Y15.12%
GM growth 3Y5.68%
GM growth 5Y6.83%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TMHC is still creating some value.
  • There is no outstanding debt for TMHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 3.93 indicates that TMHC is not in any danger for bankruptcy at the moment.
  • TMHC's Altman-Z score of 3.93 is in line compared to the rest of the industry. TMHC outperforms 60.00% of its industry peers.
  • TMHC has a debt to FCF ratio of 3.84. This is a good value and a sign of high solvency as TMHC would need 3.84 years to pay back of all of its debts.
  • TMHC has a Debt to FCF ratio (3.84) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.35 indicates that TMHC is not too dependend on debt financing.
  • The Debt to Equity ratio of TMHC (0.35) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Altman-Z 3.93
ROIC/WACC1.21
WACC9%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 6.43 indicates that TMHC has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 6.43, TMHC is doing good in the industry, outperforming 78.33% of the companies in the same industry.
  • A Quick Ratio of 0.58 indicates that TMHC may have some problems paying its short term obligations.
  • The Quick ratio of TMHC (0.58) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.43
Quick Ratio 0.58
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

  • The earnings per share for TMHC have decreased by -5.72% in the last year.
  • TMHC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.80% yearly.
EPS 1Y (TTM)-5.72%
EPS 3Y-4.7%
EPS 5Y23.8%
EPS Q2Q%-16.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.23%

3.2 Future

  • TMHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.60% yearly.
  • The Revenue is expected to decrease by -2.16% on average over the next years.
EPS Next Y-16.74%
EPS Next 2Y1.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.67%
Revenue Next 2Y-2.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.71 indicates a reasonable valuation of TMHC.
  • TMHC's Price/Earnings ratio is rather cheap when compared to the industry. TMHC is cheaper than 86.67% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.68. TMHC is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 10.46 indicates a reasonable valuation of TMHC.
  • TMHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. TMHC is cheaper than 86.67% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. TMHC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.71
Fwd PE 10.46
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 73.33% of the companies in the same industry are more expensive than TMHC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TMHC indicates a rather cheap valuation: TMHC is cheaper than 81.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.81
EV/EBITDA 6.81
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of TMHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y1.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for TMHC!.
Industry RankSector Rank
Dividend Yield 0%

TAYLOR MORRISON HOME CORP

NYSE:TMHC (2/13/2026, 8:04:00 PM)

After market: 68.86 0 (0%)

68.86

+3.39 (+5.18%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-11
Earnings (Next)04-21
Inst Owners100.87%
Inst Owner Change-95.77%
Ins Owners0.49%
Ins Owner Change-7.5%
Market Cap6.73B
Revenue(TTM)N/A
Net Income(TTM)850.94M
Analysts78.75
Price Target77.23 (12.16%)
Short Float %5.41%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.92%
Min EPS beat(2)-2.85%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)0.19%
Min EPS beat(4)-5.59%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)1.44%
EPS beat(12)7
Avg EPS beat(12)4.86%
EPS beat(16)11
Avg EPS beat(16)6.37%
Revenue beat(2)1
Avg Revenue beat(2)1.09%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)4.54%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)6
Avg Revenue beat(8)1.28%
Revenue beat(12)10
Avg Revenue beat(12)3.22%
Revenue beat(16)12
Avg Revenue beat(16)2.2%
PT rev (1m)1.79%
PT rev (3m)3.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.02%
EPS NY rev (1m)0%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 8.71
Fwd PE 10.46
P/S 0.8
P/FCF 11.81
P/OCF 11.05
P/B 1.09
P/tB 1.22
EV/EBITDA 6.81
EPS(TTM)7.91
EY11.49%
EPS(NY)6.59
Fwd EY9.56%
FCF(TTM)5.83
FCFY8.47%
OCF(TTM)6.23
OCFY9.05%
SpS85.73
BVpS63.28
TBVpS56.49
PEG (NY)N/A
PEG (5Y)0.37
Graham Number106.12
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROCE 14.26%
ROIC 10.86%
ROICexc 11.36%
ROICexgc 12.36%
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
FCFM 6.8%
ROA(3y)10.27%
ROA(5y)8.31%
ROE(3y)17.42%
ROE(5y)15.22%
ROIC(3y)12.32%
ROIC(5y)10.17%
ROICexc(3y)13.54%
ROICexc(5y)11.21%
ROICexgc(3y)15.61%
ROICexgc(5y)12.91%
ROCE(3y)16.18%
ROCE(5y)13.35%
ROICexgc growth 3Y6.33%
ROICexgc growth 5Y16.78%
ROICexc growth 3Y6.48%
ROICexc growth 5Y14.62%
OM growth 3Y8.83%
OM growth 5Y15.82%
PM growth 3Y6.96%
PM growth 5Y15.12%
GM growth 3Y5.68%
GM growth 5Y6.83%
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Debt/EBITDA 1.74
Cap/Depr 100.08%
Cap/Sales 0.47%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality 66.97%
Current Ratio 6.43
Quick Ratio 0.58
Altman-Z 3.93
F-Score7
WACC9%
ROIC/WACC1.21
Cap/Depr(3y)92.93%
Cap/Depr(5y)86.63%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.43%
Profit Quality(3y)74.16%
Profit Quality(5y)144.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.72%
EPS 3Y-4.7%
EPS 5Y23.8%
EPS Q2Q%-16.96%
EPS Next Y-16.74%
EPS Next 2Y1.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.23%
Revenue Next Year-10.67%
Revenue Next 2Y-2.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.7%
EBIT growth 3Y11.97%
EBIT growth 5Y29.02%
EBIT Next Year18.94%
EBIT Next 3Y2.89%
EBIT Next 5YN/A
FCF growth 1Y-50.16%
FCF growth 3Y-21.22%
FCF growth 5Y-13.71%
OCF growth 1Y-49.17%
OCF growth 3Y-17.68%
OCF growth 5Y-11.78%

TAYLOR MORRISON HOME CORP / TMHC FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMHC.


What is the valuation status for TMHC stock?

ChartMill assigns a valuation rating of 6 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Fairly Valued.


How profitable is TAYLOR MORRISON HOME CORP (TMHC) stock?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 7 / 10.


What is the earnings growth outlook for TAYLOR MORRISON HOME CORP?

The Earnings per Share (EPS) of TAYLOR MORRISON HOME CORP (TMHC) is expected to decline by -16.74% in the next year.